Taylor R. Jamieson

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

Marie-Ève Wedge, Victoria A. Jennings, Mathieu J. F. Crupi et al. · Nature Communications · 2022 · 46 citations · Full text

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction

Emily E. F. Brown, Reza Rezaei, Taylor R. Jamieson et al. · International Journal of Molecular Sciences · 2021 · 32 citations · Full text

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry

Taha Azad, Ragunath Singaravelu, Zaid Taha et al. · Molecular Therapy · 2021 · 26 citations · Full text

Viral Replication, Synthetic Virology, Glycobiology +18

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization

Taha Azad, Ragunath Singaravelu, Mathieu J. F. Crupi et al. · Membranes · 2020 · 24 citations · Full text

Vaccination, Viral Evolution, Vaccine Development +12

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

Stephen Boulton, Joanna Poutou, Nikolas T. Martin et al. · Molecular Therapy · 2021 · 23 citations · Full text